Who owns JHCP?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of JHCP from SEC Form 13F filings across 10 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 10 institutions disclosed 7.9M shares of JHCP worth $198.4M; the largest disclosed holder is MANUFACTURERS LIFE INSURANCE COMPANY, THE. Source: SEC Form 13F filings, parsed by EvidInvest.
10
13F holders
$198.4M
value, 2026 filers
7.9M
shares disclosed
2
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of JHCP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 6.3M | $158.4M | 0.1% | — | +47.5% |
| 2 | Cetera Investment Advisers | 637,944 | $16.0M | 0.0% | — | +13.0% |
| 3 | Coign Capital Advisors LLC | 549,891 | $13.8M | 6.2% | — | +2.6% |
| 4 | Arax Advisory PartnersNEW | 260,844 | $6.5M | 0.0% | — | new |
| 5 | ENVESTNET ASSET MANAGEMENT INC | 54,278 | $1.4M | 0.0% | — | +24.6% |
| 6 | GOLDMAN SACHS GROUP INC | 36,293 | $909,967 | 0.0% | — | -70.8% |
| 7 | CITADEL ADVISORS LLC | 31,668 | $794,005 | 0.0% | — | +74.1% |
| 8 | JANE STREET GROUP, LLC | 13,445 | $337,104 | 0.0% | — | +63.7% |
| 9 | BEAM WEALTH ADVISORS, INC. | 10,664 | $268,162 | 0.1% | — | 0.0% |
| 10 | HRT FINANCIAL LPNEW | 9,851 | $246 | 0.0% | — | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.